Latest Trials Latest NewsFAQ

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants

Not Applicable

Completed

Conditions: Patent Ductus Arteriosus

Interventions: Other: feeding
Other: fasting

First Posted Date: 2008-08-05

Last Posted Date: 2012-11-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 177

Registration Number: NCT00728117

Locations: 🇺🇸
Boston University-Boston Medical Center, Boston, Massachusetts, United States
🇺🇸
Children's Hospital-Saint Paul, Saint Paul, Minnesota, United States
🇺🇸
Atlantic Health Organization, Morristown, New Jersey, United States

and more 11 locations

Comparison of Coronary CT Angiography With Conventional Coronary Angiography in Liver and Lung Transplant Candidates

Withdrawn

Conditions: Coronary Artery Disease

First Posted Date: 2008-08-01

Last Posted Date: 2019-07-22

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00727051

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Evaluation of Vascular Pathology With 3D, Time-Resolved Phase Contrast Magnetic Resonance Imaging (MRI)

Completed

Conditions: Healthy

First Posted Date: 2008-07-28

Last Posted Date: 2013-10-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT00722904

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Tetralogy of Fallot Seed Grant

Completed

Conditions: Pulmonary Regurgitation After Repair of Tetralogy of Fallot

First Posted Date: 2008-07-28

Last Posted Date: 2015-06-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 82

Registration Number: NCT00722826

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Effects of Vitamin D on Lipids

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Hypercholesterolemia

Interventions: Other: Placebo
Dietary Supplement: Vitamin D (1000 or 2000 IU/day)

First Posted Date: 2008-07-28

Last Posted Date: 2015-04-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 130

Registration Number: NCT00723385

Locations: 🇺🇸
Jewish Home, San Francisco, California, United States

Comparison of CT Angiography With Conventional Angiography and Intravascular Ultrasound in Heart Transplant Patients

Completed

Conditions: Coronary Artery Disease
Heart Transplantation

First Posted Date: 2008-07-28

Last Posted Date: 2019-06-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18

Registration Number: NCT00723281

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Internet Stop Smoking Study - Phase VI

Not Applicable

Completed

Conditions: Smoking

Interventions: Behavioral: UCSF/SFGH Internet Stop Smoking Study site

First Posted Date: 2008-07-24

Last Posted Date: 2018-11-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18154

Registration Number: NCT00721786

Locations: 🇺🇸
University of California, San Francisco SFGH Psychiatry, San Francisco, California, United States

Intervention for (Those) Recently Informed of Seropositive Status (IRISS)

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: Skills-Building Intervention
Behavioral: Personal Interview Group

First Posted Date: 2008-07-23

Last Posted Date: 2015-03-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 160

Registration Number: NCT00720733

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Neonatal Erythropoietin in Asphyxiated Term Newborns

Phase 1

Completed

Conditions: Hypoxic-ischemic Encephalopathy

Interventions: Drug: erythropoietin

First Posted Date: 2008-07-21

Last Posted Date: 2012-11-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT00719407

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain

Not Applicable

Terminated

Conditions: Temporomandibular Joint Dysfunction Syndrome
Burning Mouth Syndrome

Interventions: Drug: nalbuphine plus placebo
Drug: nalbuphine plus naloxone

First Posted Date: 2008-07-16

Last Posted Date: 2016-05-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 46

Registration Number: NCT00716807

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy